Industry

DUBLIN–(BUSINESS WIRE)–The “Global Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Impact of COVID-19, Key Company Profiles, Recent Developments – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The global autoimmune disease diagnostics market was valued around US$ 14 Billion in 2021. The tests used to diagnose the autoimmune disease include auto … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization” report has been added to ResearchAndMarkets.com’s offering. Key Topics Covered: 1 Molecular Dx Oncology Market – Strategic Situation Analysis with Impact of the COVID-19 Pandemic 2 Guide for Executives, Marketing, Sales and Business Development … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Oligonucleotide Synthesis Markets – Forecasts by Oligo Length, Application, and Product – With Executive and Consultant Guides and including Customized Forecasting and Analysis” report has been added to ResearchAndMarkets.com’s offering. Synthetic Oligonucleotides are poised for explosive growth as gene technology moves into mainstream healthcare, food production and, even, Data Storage! The market for … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Medical Plastics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Medical Plastics Market to Reach $28.2 Billion by 2026 Plastics that are used in healthcare are typically medical-grade polymer materials that follow the regulatory standards precisely engineered for medical use or plastics that are used in consumer … [Read more…]

Fauser appointment builds on continued progress of lead AMHR2 agonist program. Celmatix lead AMHR2 agonist compound achieves in vivo PK/PD milestone. Dr. Fauser, one of the most cited investigators in reproductive health, brings deep expertise in ovarian stimulation and pathophysiology of ovarian function to Celmatix advisory board and trial committee. One of the first to … [Read more…]

Growing number of partners using needle-free to enhance vaccine effectiveness GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a biotech company that, with their innovative needle-free technology has developed a more effective way of administering drugs and biologics to accelerate research, commercialization and public health outcomes, today announced that their latest research results were presented at the BIO International Convention … [Read more…]

Study shows ilofotase alfa protects against ischemia-reperfusion induced acute kidney injury in rodents through the activation of adenosine receptors and the metabolism of extracellular adenosine triphosphate (ATP), a pro-inflammatory molecule UTRECHT, Netherlands–(BUSINESS WIRE)–AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, today announced new data indicating that ilofotase alfa protects against … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Live Cell Imaging Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global live cell imaging market is expected to grow from $3.41 billion in 2021 to $3.73 billion in 2022 at a compound annual growth rate (CAGR) of 9.2%. The market is expected to grow to $5.50 billion in … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “AL Amyloidosis – Market Insight, Epidemiology and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report deliver an in-depth understanding of the AL Amyloidosis, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Liquid Biopsy Market, Impact of COVID-19, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments – Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. The global liquid biopsy market is predicted to surpass US$ 11 Billion by 2030. The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of … [Read more…]